share_log

MetLife (NYSE:MET) Shareholders Have Earned a 15% CAGR Over the Last Five Years

MetLife (NYSE:MET) Shareholders Have Earned a 15% CAGR Over the Last Five Years

大都會人壽(紐交所:MET)股東在過去五年中每年平均獲得了15%的複合年增長率
Simply Wall St ·  08/27 13:08

If you buy and hold a stock for many years, you'd hope to be making a profit. Better yet, you'd like to see the share price move up more than the market average. Unfortunately for shareholders, while the MetLife, Inc. (NYSE:MET) share price is up 69% in the last five years, that's less than the market return. Zooming in, the stock is up a respectable 20% in the last year.

如果你買入股票並持有多年,希望能夠獲利。最好是看到股價上漲超過市場平均水平。不幸的是,對於股東而言,儘管大都會人壽(NYSE:MET)股價在過去五年中上漲了69%,但這低於市場回報率。進一步看,該股票在過去一年中上漲了可觀的20%。

So let's investigate and see if the longer term performance of the company has been in line with the underlying business' progress.

那麼,讓我們調查一下並查看公司的長期表現是否符合基本業務的進展。

While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

儘管市場是一個強大的價格機制,但股票價格反映的不僅是潛在業務績效,還反映了投資者的情緒。 了解市場情緒隨時間的變化的一種方法是查看公司的股價與每股收益(EPS)之間的互動。

During five years of share price growth, MetLife actually saw its EPS drop 8.8% per year.

在五年的股價增長期間,大都會人壽的每股收益實際上每年下降了8.8%。

Essentially, it doesn't seem likely that investors are focused on EPS. Since the change in EPS doesn't seem to correlate with the change in share price, it's worth taking a look at other metrics.

實際上,投資者似乎並沒有關注EPS。由於EPS的變化似乎與股價的變化不相關,因此值得關注其他指標。

The revenue reduction of 0.02% per year is not a positive. It certainly surprises us that the share price is up, but perhaps a closer examination of the data will yield answers.

0.02%的年收入降幅並不是一個積極的表現。股價上漲確實讓我們感到驚訝,但或許對數據進行更深入的分析會有答案。

You can see below how earnings and revenue have changed over time (discover the exact values by clicking on the image).

您可以看到以下收益和營收的變化情況(通過單擊圖像了解精確值)。

1724778504811
NYSE:MET Earnings and Revenue Growth August 27th 2024
NYSE:大都會人壽(MEt)的盈利和營業收入增長 2024年8月27日

MetLife is well known by investors, and plenty of clever analysts have tried to predict the future profit levels. Given we have quite a good number of analyst forecasts, it might be well worth checking out this free chart depicting consensus estimates.

大都會人壽爲投資者所熟知,許多聰明的分析師已經試圖預測未來的利潤水平。鑑於我們有相當數量的分析師預測,值得一看的是這張免費圖表顯示的共識估計。

What About Dividends?

那麼分紅怎麼樣呢?

It is important to consider the total shareholder return, as well as the share price return, for any given stock. The TSR incorporates the value of any spin-offs or discounted capital raisings, along with any dividends, based on the assumption that the dividends are reinvested. Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. As it happens, MetLife's TSR for the last 5 years was 101%, which exceeds the share price return mentioned earlier. And there's no prize for guessing that the dividend payments largely explain the divergence!

考慮任何給定股票的總股東回報和股價回報是很重要的。TSR包括任何分拆或折價融資的價值,以及任何根據股息再投資的股息。可以說,TSR更全面地展示了股票所產生的回報。碰巧的是,大都會人壽過去5年的TSR爲101%,超過了前文提到的股價回報。毫無疑問,股息支付在很大程度上解釋了這種差異!

A Different Perspective

不同的觀點

MetLife shareholders gained a total return of 23% during the year. But that was short of the market average. On the bright side, that's still a gain, and it's actually better than the average return of 15% over half a decade This suggests the company might be improving over time. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Case in point: We've spotted 1 warning sign for MetLife you should be aware of.

在過去的一年裏,大都會人壽的股東獲得了總回報率爲23%。但這仍然不及市場平均水平。好消息是,這仍然是個盈利,實際上比過去五年15%的平均回報更好。這表明公司可能隨着時間的推移在改善。我發現長期來看股價作爲業務表現的一種代理非常有趣。但爲了真正獲得見解,我們還需要考慮其他信息。譬如:我們發現了一個關於大都會人壽的1個警示信號,你應該注意。

For those who like to find winning investments this free list of undervalued companies with recent insider purchasing, could be just the ticket.

對於那些喜歡尋找獲勝投資的人來說,最近有內部購買的低估公司免費列表可能是一個很好的選擇。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

請注意,本文所引述的市場回報反映了目前在美國交易所上市的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論